Syra Health Corp.

Company Overview

Business Model: SYRA HEALTH CORP. is a healthcare services company focused on promoting preventative health, holistic wellness, health education, and equitable healthcare. The company leverages scientific and healthcare expertise to develop patient-centric solutions aimed at improving patient lives and health outcomes. SYRA HEALTH CORP. provides comprehensive end-to-end solutions across behavioral and mental health, population health, digital health, health education, and healthcare workforce segments. Its offerings emphasize prevention, improved access, and affordable care, targeting payers, providers, life sciences organizations, academic institutions, and government entities.

Market Position: SYRA HEALTH CORP. operates in highly competitive healthcare services markets, facing competition from healthcare consulting service providers, healthcare payment accuracy companies, and providers of data products and analytics solutions. The company also competes with some of its customers who offer similar internal solutions. Competitors include entities with significantly larger financial and other resources. The increasing standardization of certain healthcare services has lowered barriers to entry for new competitors. SYRA HEALTH CORP. aims to differentiate through continuous innovation and high-quality, competitively priced solutions.

Recent Strategic Developments: SYRA HEALTH CORP. launched Syrenity, a proprietary behavioral and mental health application, in the fourth quarter of 2024. Syrenity is designed for preventative care and interventions, utilizing an artificial intelligence-driven user diary for engagement, symptom monitoring, and timely interventions like cognitive behavioral therapy and mindfulness techniques. The company is preparing for Syrenity's global market launch and is continually advancing its scientific foundation and AI technology. SYRA HEALTH CORP. is also expanding its government solutions service line to pursue federal healthcare projects with agencies such as the United States Department of Health and Human Services, the Centers for Disease Control and Prevention, the National Institutes of Health, the National Aeronautics and Space Administration, and the United States Department of Defense. Growth strategies include expanding operations to other metropolitan areas, growing sales and business development teams, investing in partnerships with subject matter experts, and potentially acquiring companies with similar service lines.

Geographic Footprint: SYRA HEALTH CORP.'s corporate headquarters are located in Carmel, Indiana. The company's primary customer base includes state and local government health agencies, with a significant concentration of revenue and accounts receivable from the Indiana Family and Social Services Administration (FSSA). SYRA HEALTH CORP. recruits healthcare professionals for positions at facilities "across the country" and plans to open offices in multiple geographical locations to support sales and business development efforts. The company is also preparing for the launch of its Syrenity application in global markets.

Financial Performance

Revenue Analysis

Profitability Metrics:

• Gross Margin: 20.7% (2024), 25.6% (2023)
• Operating Margin: -47.2% (2024), -52.4% (2023)
• Net Margin: -47.1% (2024), -53.3% (2023)

Investment in Growth:

• R&D Expenditure: $585,146 (7.3% of revenue) in 2024, up from $240,048 (4.3% of revenue) in 2023, primarily for the Syrenity application.
• Capital Expenditures: $11,111 in 2024, $15,251 in 2023, primarily for property and equipment.
• Strategic Investments: SYRA HEALTH CORP. may expand its footprint by acquiring companies that offer similar service lines, though no specific amounts for such investments were disclosed for the reporting period.

Business Segment Analysis

Healthcare Workforce

Financial Performance:

• Revenue: $5,896,433 (+38.4% YoY)
• Key Growth Drivers: New customer acquisitions and additions to existing contracts.
• Future Outlook: A contract with FSSA (NeuroDiagnostic Institute) completed on January 31, 2025, is expected to result in a decline in healthcare workforce revenue. A new contract with FSSA (NeuroDiagnostic Institute) has been executed with a ceiling value of approximately $1,480,000, ending June 30, 2025.

Product Portfolio:

• Recruitment of experienced nurses and allied health professionals for long-term fixed contract positions at hospitals and healthcare facilities nationwide.
• Staffing for care coordinators, healthcare management specialists, healthcare educators, therapists, healthcare technicians, and health plan specialists.

Market Dynamics:

• The U.S. healthcare staffing market was valued at $36.9 billion in 2022 and is projected to grow at a CAGR of 6.93% from 2023 to 2030.
• Global demand for health workers is predicted to rise significantly by 2030, with a projected net shortage of approximately 15 million health workers globally.
• Mercer projects a deficit of over 100,000 healthcare workers in the U.S. by 2028.

Population Health

Financial Performance:

• Revenue: $1,659,804 (+132.0% YoY)
• Key Growth Drivers: Additional services provided to state departments and other customers.

Product Portfolio:

• End-to-end solutions and strategies to improve quality of care, access to care, health outcomes, and healthcare policies.
• Services include analytics as a service, epidemiology, and health equity analytics solutions.
• Team of health economists, public health experts, data scientists, and biostatisticians apply advanced health analytics to provide insights for clinical care, risk stratification, resource utilization prediction, and population-level strategies.

Market Dynamics:

• The U.S. population health management market was valued at $25.0 billion in 2022 and is anticipated to grow at a CAGR of 19.5% from 2022 to 2030, reaching $103.7 billion.
• Growth is driven by increasing demand for healthcare IT services and solutions supporting value-based healthcare delivery.
• The U.S. healthcare quality management market was valued at $3.2 billion in 2020 and is projected to reach $6.8 billion by 2028, growing at a CAGR of 13.2%.

Digital Health

Financial Performance:

• Revenue: $369,000 (-28.4% YoY)
• Key Growth Drivers: The decline in revenue was attributed to a phased transition from implementation to maintenance and operational support services.

Product Portfolio:

• Digital and cloud-based platforms aimed at improving cost savings through automation of health operations and providing clinical insights for personalized care.
• Solutions include digital transformation, cloud and security, artificial intelligence, patient engagement, and health applications.
• Intends to offer SyraBot (an AI-powered chatbot for patient engagement and information access) and CarePlus (an electronic medical records solution for small to mid-sized healthcare organizations).

Market Dynamics:

• The U.S. digital health market size was estimated at $81.17 billion in 2023 and is projected to grow at a CAGR of 19.5% from 2024 to 2030.
• This market includes mobile health applications, wearable devices, telemedicine, and telehealth services.
• Advancements in telehealth technologies are driving growth as healthcare providers adopt digital solutions for patient management.

Behavioral and Mental Health

Financial Performance:

• Revenue: $16,845 (+31.6% YoY)

Product Portfolio:

• Syrenity, a comprehensive mental health application, launched in Q4 2024. It provides preventative care and interventions, utilizing an AI-driven user diary, targeted assignments, education, symptom monitoring, and interventions like cognitive behavioral therapy and mindfulness techniques.
• Syrenity enables users to connect with licensed mental health professionals for virtual consultations and provides educational resources.

Market Dynamics:

• The U.S. behavioral health market was valued at $151.7 billion in 2023 and is expected to grow at a CAGR of 3.7% from 2024 to 2032.
• Key drivers include rising awareness of mental health issues, increased access to care, and growing adoption of telehealth services.
• Statistics indicate significant mental illness prevalence among U.S. adults and youth, with suicide being a leading cause of death for ages 10-34.

Health Education Services

Financial Performance:

• Revenue: $40,000 (+225.0% YoY)

Product Portfolio:

• Medical education solutions for pharmaceutical and medical device manufacturers, biotechnology companies, payers, large employers, academic institutions, and government agencies.
• Develops medical education content to support client organizational and strategic brand goals.
• Utilizes omnichannel delivery approaches (in-person, virtual, hybrid) and traditional print/electronic formats.
• Incorporates artificial intelligence tools to provide real-time information to customers.
• Services include medical communications, patient education, and healthcare training.

Market Dynamics:

• The U.S. health education market was valued at $110 billion in 2023 and is projected to reach approximately $280.6 billion by 2033, growing at a CAGR of 11.0%.
• The U.S. continuing medical education market was valued at approximately $2,712.6 million in 2021 and is expected to reach approximately $3,830.5 million by 2027.
• The medical writing market in the U.S. is expected to exceed $5,285.3 billion by 2030 at a CAGR of 10.31%.
• Key drivers include technological advancements (e-learning, AI, VR), increasing demand for healthcare professionals, and government support.

Capital Allocation Strategy

Shareholder Returns:

• Share Repurchases: SYRA HEALTH CORP. did not engage in any share repurchases during the reported period.
• Dividend Payments: The company has never paid cash dividends and does not anticipate doing so in the foreseeable future, intending to retain all available funds and future earnings for business development and expansion.
• Future Capital Return Commitments: No specific future capital return commitments were disclosed.

Balance Sheet Position:

• Cash and Equivalents: $2,395,405 as of December 31, 2024, down from $3,280,075 as of December 31, 2023.
• Total Debt: $152,887 in current notes payable as of December 31, 2024. There was no non-current debt.
• Net Cash Position: $2,242,518 as of December 31, 2024.
• Debt Maturity Profile: Insurance notes payable have monthly payments due through July 2025.

Cash Flow Generation:

• Operating Cash Flow: $(2,932,033) in 2024, compared to $(2,759,068) in 2023, primarily due to net losses.
• Free Cash Flow: $(2,943,144) in 2024 (Operating Cash Flow less Capital Expenditures).
• Cash Conversion Metrics: Not explicitly detailed in the filing.

Operational Excellence

Production & Service Model: SYRA HEALTH CORP. delivers comprehensive end-to-end solutions. For healthcare workforce services, it employs agile implementation staffing methodologies to efficiently expand client clinical personnel. In health education, the company utilizes omnichannel delivery approaches, including in-person, virtual, and hybrid arrangements, with deliverables in traditional print and electronic formats. Artificial intelligence tools are integrated into targeted education approaches to provide real-time information to customers. The Syrenity mental health application is designed with an AI-driven user diary for engagement and interventions.

Supply Chain Architecture: Key Suppliers & Partners:

• Recruitment and Human Resource Services: NLogix (a related party) - $516,129 in 2024 and $348,304 in 2023.
• IT Services: RAD CUBE LLC (a related party) - $22,233 in 2024 and $3,320 in 2023.
• Content Providers: Independent content providers are utilized for the development of health education and other scientific content resources.

Facility Network:

• Corporate Headquarters: Located at 1119 Keystone Way N. #201 Carmel, IN 46032, leased from STVentures, LLC (a related party). The lease was amended on June 26, 2024, for a three-year term with a base monthly rent of $11,209.
• Expansion: SYRA HEALTH CORP. plans to open offices in multiple geographical locations to support sales and business development efforts.
• Research & Development: R&D expenses are incurred for the continued development of the Syrenity application, though specific R&D facilities are not detailed.

Operational Metrics:

• Gross profit margin decreased from approximately 26% in 2023 to 21% in 2024. This decrease was primarily due to an increase in labor costs associated with the increased volume of contracts and increased consulting costs related to a slight change in service mix towards project-based population health services.

Market Access & Customer Relationships

Go-to-Market Strategy: Distribution Channels:

• Direct Sales: SYRA HEALTH CORP. is expanding its sales and business development teams to acquire new customers and increase sales to existing ones.
• Government Contracts: The company actively pursues federal government healthcare projects through its government solutions service line, targeting agencies such as the United States Department of Health and Human Services, the Centers for Disease Control and Prevention, the National Institutes of Health, the National Aeronautics and Space Administration, and the United States Department of Defense.
• Digital Platforms: The company is developing and offering digital and cloud-based platforms, including the Syrenity mental health application, SyraBot chatbot, and CarePlus electronic medical records solution.

Customer Portfolio: Enterprise Customers:

• Major Clients: The Indiana Family and Social Services Administration (FSSA) is a significant customer, accounting for approximately 61% of total revenues in 2024 and 68% in 2023. This includes revenues from the FSSA-NeuroDiagnostic Institute ($4,567,637 in 2024) and the FSSA-Division of Mental Health and Addiction ($312,000 in 2024).
• Customer Concentration: FSSA represented 56% of accounts receivable at December 31, 2024, with one other customer accounting for 11%. In 2023, FSSA represented 30% of outstanding accounts receivable.
• Target Customers: SYRA HEALTH CORP. aims to serve payers, providers, life sciences organizations, academic institutions, and government entities. Specific segments target health organizations, large employers, schools, pharmaceutical and medical device manufacturers, and biotechnology companies.

Geographic Revenue Distribution:

• Revenue is primarily concentrated in the United States, particularly with state government agencies in Indiana.
• SYRA HEALTH CORP. plans to expand its physical presence by opening offices in multiple geographical locations across the country.
• The Syrenity application is being strategically prepared for launch in global markets.

Competitive Intelligence

Market Structure & Dynamics

Industry Characteristics: The healthcare services markets are characterized by substantial competition and rapid change. The increasing standardization of certain healthcare services facilitates market entry for new competitors. Key market segments, such as U.S. behavioral health ($151.7 billion in 2023, CAGR 3.7% to 2032), population health management ($25.0 billion in 2022, CAGR 19.5% to 2030), digital health ($81.17 billion in 2023, CAGR 19.5% to 2030), health education ($110 billion in 2023, CAGR 11.0% to 2033), and healthcare staffing ($36.9 billion in 2022, CAGR 6.93% to 2030), demonstrate significant growth potential driven by factors like rising awareness of health issues, demand for IT solutions, aging populations, and technological advancements. Industry consolidation among healthcare provider organizations is also a notable dynamic, potentially increasing competition and pricing pressures.

Competitive Positioning Matrix:

Direct Competitors

Primary Competitors: SYRA HEALTH CORP. competes with healthcare consulting service providers, healthcare payment accuracy companies, and providers of data products and analytics solutions. In the healthcare workforce segment, it competes with other healthcare staffing companies, recruitment and placement agencies (including online platforms), and internal staffing efforts by hospitals and healthcare facilities. Many competitors are significantly larger and possess greater financial and other resources.

Emerging Competitive Threats: The company faces threats from new entrants and companies in adjacent product or service areas that may launch competitive offerings. Future advances in healthcare services technology could render existing solutions obsolete or less competitive. New technologies and processes, such as more sophisticated internal staffing management and recruitment tools, could also reduce demand for SYRA HEALTH CORP.'s services.

Competitive Response Strategy: SYRA HEALTH CORP. aims to maintain its competitive advantage by continuously upgrading existing solutions and introducing new, valuable offerings in response to regulatory developments and customer demands. The company focuses on providing high-quality, innovative products at competitive prices. Strategic initiatives include investing in partnerships with subject matter experts to enhance service lines and considering acquisitions of companies with similar service lines to expand its footprint.

Risk Assessment Framework

Strategic & Market Risks

Market Dynamics:

• Future Profitability Uncertainty: SYRA HEALTH CORP. has incurred recurring net losses ($3,759,238 in 2024 and $2,938,343 in 2023) and an accumulated deficit of $8,824,193 as of December 31, 2024, raising substantial doubt about its ability to continue as a going concern without additional capital.
• Need for Additional Funding: The company will require substantial additional funding as existing cash and expected revenue are not sufficient to fund operations for at least the next twelve months. Inability to raise capital on favorable terms could force curtailment or discontinuation of business.
• Competition: Substantial competition from larger, better-resourced entities, and the ease of market entry due to standardization, could lead to obsolescence, market share loss, or price erosion.
• Customer Retention and Acquisition: Failure to continuously update and improve solutions, respond to pricing pressures, or address changing business models could hinder customer retention and attraction.
• Cross-selling Dependence: Future revenue and growth depend on successful cross-selling of solutions, which may not materialize if customers find additional offerings unnecessary or cost-ineffective.
• Economic Downturn or Volatility: Weakening economic conditions could reduce demand for solutions, increase competitive pricing pressure, lead to customer creditworthiness declines, and result in contract terminations or non-renewals, particularly for staffing services.

Operational & Execution Risks

Supply Chain Vulnerabilities:

• Independent Content Providers: Reliance on third-party content providers for health education and scientific content poses risks if providers fail to perform adequately, comply with regulations, or deliver high-quality content.
• IT Systems and Data Security: Operations are vulnerable to interruptions, damages, system failures, cyber and ransomware attacks, computer viruses, hacking, and employee malfeasance. Breaches could lead to significant liability, reputational harm, and increased security costs.
• Service-Related Liabilities: Solutions providing information for patient care could lead to claims or litigation for misdiagnoses, mistreatment, or injury if data is incorrect or incomplete, potentially exceeding insurance coverage.
• Contract Underpricing and Cost Overruns: Grant writing and fixed-fee contracts carry risks of underpricing or cost overruns, which could materially impact financial results if change orders are not successfully negotiated.
• Expansion Demands: Growth into new services, clients, and geographic locations places substantial demands on management, personnel, and systems, potentially leading to increased operating risks and costs.

Financial & Regulatory Risks

Market & Financial Risks:

• Loss Carryforwards Limitations: The ability to utilize federal net operating losses (NOLs) of approximately $8,265,000 may be limited by Sections 382 and 383 of the Internal Revenue Code due to potential ownership changes.
• Changes in Tax Laws: Unanticipated changes in U.S. federal, state, and local tax laws, including provisions from the Inflation Reduction Act of 2022 (e.g., minimum tax on global adjusted financial statement income, excise tax on share repurchases), could adversely affect future profitability.
• Market Price Volatility: The market price of Class A common stock is highly volatile and subject to fluctuations due to various factors, including development failures, regulatory changes, funding issues, and general economic conditions.
• Financial Institution Instability: Broader financial market volatility and adverse developments with financial institutions could create liquidity risk, making debt or equity financing more difficult and costly.

Regulatory & Compliance Risks:

• Extensive Healthcare Regulation: The business is heavily regulated by federal and state laws, including the Anti-Kickback Statute, False Claims Act, and data privacy laws (HIPAA). Non-compliance could lead to investigations, civil/criminal penalties, and exclusion from government programs.
• Government Contracting Risks: Contracts with government entities are subject to stringent procurement laws, audits, investigations, and potential sanctions, including contract termination or debarment.
• Data Security and Privacy Laws: Compliance with HIPAA and state data protection laws requires robust safeguards for protected health information. Failure to comply can result in regulatory enforcement, fines, and private litigation.
• Legal Proceedings: The company may be party to legal and regulatory proceedings, which are inherently unpredictable, costly, and can divert management attention.
• Nasdaq Delisting Risk: Failure to meet Nasdaq's continued listing standards (e.g., minimum shareholder equity, minimum bid price) could result in delisting, reduced liquidity, and impaired ability to raise capital.

Geopolitical & External Risks

• Geographic Dependencies: Not explicitly detailed beyond general market/economic conditions.
• Trade Relations: Not explicitly detailed beyond general FCPA mention.
• Sanctions & Export Controls: The U.S. Foreign Corrupt Practices Act (FCPA) applies to interactions with certain healthcare professionals in many countries, posing compliance requirements.
• Health Epidemics and Outbreaks: Health epidemics (e.g., COVID-19) or other natural/man-made disasters could significantly disrupt operations.

Innovation & Technology Leadership

Research & Development Focus: Core Technology Areas:

• Artificial Intelligence (AI): Central to the Syrenity mental health application for user engagement and interventions, utilized in targeted health education approaches for real-time information, and foundational for the SyraBot chatbot.
• Digital Health Platforms: Development of digital and cloud-based platforms to automate health operations, provide clinical insights, and enhance patient care and engagement. This includes Syrenity, SyraBot, and CarePlus (an electronic medical records solution).
• Advanced Health Analytics: Applied within population health services by a team of experts to analyze real-world data, stratify health risks, predict resource utilization, and recommend population-level strategies.

Innovation Pipeline:

• Syrenity: Launched in Q4 2024, with strategic plans for global market launch and continuous advancement of its scientific foundation and AI technology to improve user outcomes.
• SyraBot: An AI-powered chatbot intended to provide round-the-clock information and foster connectivity throughout individuals' care journeys.
• CarePlus: An electronic medical records solution designed for small to mid-sized healthcare organizations, which the company intends to offer.

Intellectual Property Portfolio:

• Patent Strategy: SYRA HEALTH CORP. relies on a combination of trade secret, copyright, trademark laws, patents, license agreements, confidentiality procedures, nondisclosure agreements, and technical measures to protect its intellectual property. The company acknowledges that protecting these rights requires substantial resources and may not always be adequate.
• IP Litigation: Litigation may be necessary to enforce and protect intellectual property rights, which could be expensive, divert management resources, and potentially compromise confidential information.

Technology Partnerships:

• SYRA HEALTH CORP. intends to invest in partnerships with subject matter experts to further enhance its service lines and provide real-world insights, though specific technology partnerships were not detailed.

Leadership & Governance

Executive Leadership Team

Leadership Continuity: SYRA HEALTH CORP. is highly dependent on its personnel, particularly Deepika Vuppalanchi, whose loss could impede business objectives. The company does not hold key-person life insurance. Future success relies on the ability to identify, attract, hire, and retain highly qualified management and scientific personnel in a competitive industry.

Board Composition: The principal stockholders, including Deepika Vuppalanchi and Priya Prasad, collectively own a significant portion of the voting securities (Deepika Vuppalanchi, Sandeep Allam, and Priya Prasad beneficially own 51.0% of Class B common stock and 30.9% of total voting securities as of December 31, 2024). This concentrated control provides significant influence over the election of the board of directors and approval of major corporate actions.

Human Capital Strategy

Workforce Composition:

• Total Employees: As of March 7, 2025, SYRA HEALTH CORP. employed 57 full-time and 37 part-time employees.
• Geographic Distribution: Employees are recruited for positions at hospitals and healthcare facilities "across the country."
• Skill Mix: The workforce includes skilled management and scientific personnel, experienced nurses and allied health professionals, care coordinators, healthcare management specialists, healthcare educators, therapists, healthcare technicians, and health plan specialists.

Talent Management: Acquisition & Retention:

• Hiring Strategy: The company's revenue growth and profitability depend on its success in recruiting, training, and retaining a sufficient number of sales personnel. Competition for qualified personnel in the healthcare services industry is intense.
• Retention Metrics: Not explicitly disclosed.
• Employee Value Proposition: SYRA HEALTH CORP. competes for healthcare professionals based on assignment quantity, diversity, quality, compensation packages, benefits, and service speed and quality.

Diversity & Development:

• Not explicitly detailed in the filing.

Environmental & Social Impact

Environmental Commitments:

• No specific environmental commitments or targets (e.g., emissions, carbon neutrality, renewable energy) were explicitly disclosed in the filing.

Supply Chain Sustainability:

• No specific supply chain sustainability initiatives (e.g., ESG requirements for suppliers, responsible sourcing) were explicitly disclosed in the filing.

Social Impact Initiatives:

• SYRA HEALTH CORP.'s core mission includes promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics.
• The company is committed to behavioral and mental health equity, aiming to provide solutions that improve healthcare access for all populations, regardless of race, ethnicity, gender, socioeconomic status, sexual orientation, or geographic location.
• Product development, such as the Syrenity mental health application, is aimed at providing preventative care and interventions for behavioral and mental health.
• Digital health solutions are designed to transform patient care and engagement by connecting various stakeholders.

Business Cyclicality & Seasonality

Demand Patterns:

• Economic Sensitivity: Demand for SYRA HEALTH CORP.'s staffing services is sensitive to changes in economic activity. Economic downturns or periods of high inflation, which can lead to reduced consumer spending and decreased hospital admissions, typically result in lower demand for temporary healthcare professionals. Conversely, permanent staff may work more hours, further reducing demand for external staffing services.
• Seasonal Trends: No specific seasonal trends in demand were explicitly disclosed in the filing.
• Industry Cycles: The company's business is influenced by broader economic and healthcare industry cycles, particularly those affecting hospital admissions and healthcare facility staffing needs.

Planning & Forecasting:

• No specific details on demand forecasting, inventory management, or capacity planning were explicitly disclosed in the filing.

Regulatory Environment & Compliance

Regulatory Framework: Industry-Specific Regulations:

• SYRA HEALTH CORP. operates in a heavily regulated environment, subject to extensive federal and state laws governing healthcare operations, costs, payment for services, and referrals. These include the Anti-Kickback Statute, False Claims Act, Stark Law, and the Sunshine Act.
• The company's marketing practices are also subject to state and federal laws preventing fraud and abuse in the healthcare industry.
• Many of these laws are vague, and their interpretation or application by authorities could necessitate operational changes and incur additional expenses.

Trade & Export Controls:

• The U.S. Foreign Corrupt Practices Act (FCPA) prohibits payments to foreign government officials to obtain or retain business abroad, impacting interactions with certain healthcare professionals in other countries.

Legal Proceedings:

• SYRA HEALTH CORP. is subject to various legal and regulatory proceedings in the ordinary course of business.
• In January 2024, a former employee filed a wrongful termination lawsuit, which was settled for an immaterial amount in January 2025 and dismissed.
• The company is also subject to investigations and proceedings in the healthcare industry generally, seeking recovery under HIPAA, the Anti-Kickback Statute, and the False Claims Act.

Tax Strategy & Considerations

Tax Profile:

• Effective Tax Rate: SYRA HEALTH CORP.'s effective income tax rate was 0% for both 2024 and 2023, primarily due to a full valuation allowance against its net deferred tax assets.
• Net Operating Losses (NOLs): As of December 31, 2024, the company had approximately $8,265,000 in federal net operating losses. Federal NOLs incurred after December 31, 2017, can be carried forward indefinitely but are limited to 80% of taxable income annually for tax years beginning after December 31, 2020.
• Valuation Allowance: A full valuation allowance has been provided against net deferred tax assets due to management's assessment that it is more likely than not that these assets will not be fully realizable, given the company's history of losses.
• Tax Reform Impact: The company is subject to U.S. federal, state, and local taxes. Recent tax law changes, such as the Tax Cuts and Jobs Act of 2017, the CARES Act, and the Inflation Reduction Act of 2022 (which includes a 15% minimum tax on global adjusted financial statement income and a 1% excise tax on share repurchases), could affect future financial results.

Insurance & Risk Transfer

Risk Management Framework:

• Insurance Coverage: SYRA HEALTH CORP. maintains liability insurance coverage, including cyber-liability coverage. However, there is a risk that claims could be denied, exceed coverage limits, or that adequate coverage may not be available on acceptable terms in the future.
• Risk Transfer Mechanisms: The company attempts to limit its liability for damages arising from negligence, errors, mistakes, or security breaches through contractual provisions. However, these limitations may not always be accepted by customers or be legally enforceable.